Champions Oncology, Inc.CSBRNASDAQ
LOADING
|||
Analyst Sentiment
Analysts lean bullish — 71% recommend buying.
Consensus Rating
Buy
7 analysts·Limited coverage
71%
Rating Distribution
Strong Buy
00%
Buy
571%
Hold
229%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Analysts see significant upside — consensus target 64% higher.
Bear Case
$12.00
+64%
Consensus
$12.00
+64%
Bull Case
$12.00
+64%
Price Range7 analysts
Low
Consensus
High
$12.00
$12.00
Current Target
Current Price
$7.31
Upside to Target
$4.69
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.